Literature DB >> 11898497

The role of neuroimaging in selecting treatments for patients with acute stroke.

D Greer1, J Oliveira-Filho, W J Koroshetz.   

Abstract

The armamentarium available for treating acute stroke patients is growing as clinical trials show benefit of intravenous thrombolysis, intra-arterial clot lysis, and antiplatelet agents. Patients with dissection or severe atheromatous stenosis of major cerebrovascular vessels are commonly treated with anticoagulation to prevent recurrent artery-to-artery embolus or arterial thrombosis. These advances in acute stroke treatments demand an accurate means to quickly identify those patients most likely to benefit (or not benefit) from a specific therapy. Fortunately, advances in imaging cerebrovascular lesions, decreased brain perfusion, and even ischemic tissue injury now make it possible to consider tailoring therapy to the individual patient's cerebrovascular problem. Experience and controlled clinical data in this endeavor is meager. Here we describe the ability of various emergency neuroimaging tools to provide information on the state of brain blood flow, metabolism, and vascular anatomy. Most importantly, we present the rationale and limited available evidence relevant to how the neuroimaging information might be used to select optimal treatments for individual patients.

Entities:  

Mesh:

Year:  2001        PMID: 11898497     DOI: 10.1007/s11910-001-0074-y

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  40 in total

1.  Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy.

Authors:  M E Moseley; Y Cohen; J Mintorovitch; L Chileuitt; H Shimizu; J Kucharczyk; M F Wendland; P R Weinstein
Journal:  Magn Reson Med       Date:  1990-05       Impact factor: 4.668

2.  Dynamic CT measurement of cerebral blood flow: a validation study.

Authors:  A Cenic; D G Nabavi; R A Craen; A W Gelb; T Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

3.  Temporal evolution of ischemic injury evaluated with diffusion-, perfusion-, and T2-weighted MRI.

Authors:  F Li; M D Silva; C H Sotak; M Fisher
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

4.  Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke.

Authors:  S Wildermuth; M Knauth; T Brandt; R Winter; K Sartor; W Hacke
Journal:  Stroke       Date:  1998-05       Impact factor: 7.914

5.  Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI.

Authors:  G Rordorf; W J Koroshetz; W A Copen; S C Cramer; P W Schaefer; R F Budzik; L H Schwamm; F Buonanno; A G Sorensen; G Gonzalez
Journal:  Stroke       Date:  1998-05       Impact factor: 7.914

6.  Potential of CT angiography in acute ischemic stroke.

Authors:  M Knauth; R von Kummer; O Jansen; S Hähnel; A Dörfler; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1997 Jun-Jul       Impact factor: 3.825

7.  Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.

Authors:  M P Marks; D C Tong; C Beaulieu; G W Albers; A de Crespigny; M E Moseley
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

8.  Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats : correlation with histopathology.

Authors:  F Li; K F Liu; M D Silva; T Omae; C H Sotak; J D Fenstermacher; M Fisher; C Y Hsu; W Lin
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

9.  Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection.

Authors:  G W Albers
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

10.  Clinical experience with diffusion-weighted MR in patients with acute stroke.

Authors:  K O Lövblad; H J Laubach; A E Baird; F Curtin; G Schlaug; R R Edelman; S Warach
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.